الصفحة الرئيسية>>Signaling Pathways>> Microbiology & Virology>> HSV>>Glyceryl monocaprate

Glyceryl monocaprate

رقم الكتالوجGC38915

الجليسريل أحادي الكبريت (Monolaurin) هو أحادي الجليسريد من حمض الكابريك ضد الالتهابات البكتيرية إيجابية الجرام

Products are for research use only. Not for human use. We do not sell to patients.

Glyceryl monocaprate التركيب الكيميائي

Cas No.: 26402-22-2

الحجم السعر المخزون الكميّة
100mg
56٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Glyceryl monocaprate (Monolaurin) is a 1-monoglyceride of capric acid against gram-positive bacterial infections[1]. Glyceryl monocaprate (Monolaurin) has inhibitory effect on Herpes Simplex Virus (HSV) and offers an effective treatment for herpes labialiss[2].

Glyceryl monocaprate (Monolaurin) has an antimicrobial activity against gram-positive ATCC SA 29123[1].

Glyceryl monocaprate (Monolaurin) combines with low-dose doxycycline offers an effective treatment for herpes labialiss, significantly reducing time to healing and pain compared with the placebo and monocaprin alone[2].

[1]. Chan WY, et al. In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa.Vet Dermatol. 2019 Apr;30(2):133-e38. [2]. Skulason S, et al. A study of the clinical activity of a gel combining monocaprin and doxycycline: a novel treatment for herpes labialis.J Oral Pathol Med. 2012 Jan;41(1):61-7.

مراجعات

Review for Glyceryl monocaprate

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Glyceryl monocaprate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.